The role of mesenchymal stem cells derived exosomes as a novel nanobiotechnology target in the diagnosis and treatment of cancer

Mesenchymal stem cells (MSCs), one of the most common types of stem cells, are involved in the modulation of the tumor microenvironment (TME). With the advancement of nanotechnology, exosomes, especially exosomes secreted by MSCs, have been found to play an important role in the initiation and devel...

Full description

Bibliographic Details
Main Authors: You Zhou, Yuqing Dong, Aixue Zhang, Jibin Wu, Qiang Sun
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fbioe.2023.1214190/full
_version_ 1797741408245776384
author You Zhou
Yuqing Dong
Aixue Zhang
Jibin Wu
Qiang Sun
author_facet You Zhou
Yuqing Dong
Aixue Zhang
Jibin Wu
Qiang Sun
author_sort You Zhou
collection DOAJ
description Mesenchymal stem cells (MSCs), one of the most common types of stem cells, are involved in the modulation of the tumor microenvironment (TME). With the advancement of nanotechnology, exosomes, especially exosomes secreted by MSCs, have been found to play an important role in the initiation and development of tumors. In recent years, nanobiotechnology and bioengineering technology have been gradually developed to detect and identify exosomes for diagnosis and modify exosomes for tumor treatment. Several novel therapeutic strategies bioengineer exosomes to carry drugs, proteins, and RNAs, and further deliver their encapsulated cargoes to cancer cells through the properties of exosomes. The unique properties of exosomes in cancer treatment include targeting, low immunogenicity, flexibility in modification, and high biological barrier permeability. Nevertheless, the current comprehensive understanding of the roles of MSCs and their secreted exosomes in cancer development remain inadequate. It is necessary to better understand/update the mechanism of action of MSCs-secreted exosomes in cancer development, providing insights for better modification of exosomes through bioengineering technology and nanobiotechnology. Therefore, this review focuses on the role of MSCs-secreted exosomes and bioengineered exosomes in the development, progression, diagnosis, and treatment of cancer.
first_indexed 2024-03-12T14:26:16Z
format Article
id doaj.art-637b3f42c4024132ad5537e0d41619c0
institution Directory Open Access Journal
issn 2296-4185
language English
last_indexed 2024-03-12T14:26:16Z
publishDate 2023-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Bioengineering and Biotechnology
spelling doaj.art-637b3f42c4024132ad5537e0d41619c02023-08-18T05:23:42ZengFrontiers Media S.A.Frontiers in Bioengineering and Biotechnology2296-41852023-08-011110.3389/fbioe.2023.12141901214190The role of mesenchymal stem cells derived exosomes as a novel nanobiotechnology target in the diagnosis and treatment of cancerYou Zhou0Yuqing Dong1Aixue Zhang2Jibin Wu3Qiang Sun4Department of Plastic Surgery, The First Hospital of China Medical University, Shenyang, ChinaChina Medical University and Department of Pathology, Shenyang, ChinaDepartment of Plastic Surgery, The First Hospital of China Medical University, Shenyang, ChinaDepartment of Plastic Surgery, The First Hospital of China Medical University, Shenyang, ChinaDepartment of Plastic Surgery, The First Hospital of China Medical University, Shenyang, ChinaMesenchymal stem cells (MSCs), one of the most common types of stem cells, are involved in the modulation of the tumor microenvironment (TME). With the advancement of nanotechnology, exosomes, especially exosomes secreted by MSCs, have been found to play an important role in the initiation and development of tumors. In recent years, nanobiotechnology and bioengineering technology have been gradually developed to detect and identify exosomes for diagnosis and modify exosomes for tumor treatment. Several novel therapeutic strategies bioengineer exosomes to carry drugs, proteins, and RNAs, and further deliver their encapsulated cargoes to cancer cells through the properties of exosomes. The unique properties of exosomes in cancer treatment include targeting, low immunogenicity, flexibility in modification, and high biological barrier permeability. Nevertheless, the current comprehensive understanding of the roles of MSCs and their secreted exosomes in cancer development remain inadequate. It is necessary to better understand/update the mechanism of action of MSCs-secreted exosomes in cancer development, providing insights for better modification of exosomes through bioengineering technology and nanobiotechnology. Therefore, this review focuses on the role of MSCs-secreted exosomes and bioengineered exosomes in the development, progression, diagnosis, and treatment of cancer.https://www.frontiersin.org/articles/10.3389/fbioe.2023.1214190/fullmesenchymal stem cellsexosomesbiotechnologycancer therapycancer diagnosis
spellingShingle You Zhou
Yuqing Dong
Aixue Zhang
Jibin Wu
Qiang Sun
The role of mesenchymal stem cells derived exosomes as a novel nanobiotechnology target in the diagnosis and treatment of cancer
Frontiers in Bioengineering and Biotechnology
mesenchymal stem cells
exosomes
biotechnology
cancer therapy
cancer diagnosis
title The role of mesenchymal stem cells derived exosomes as a novel nanobiotechnology target in the diagnosis and treatment of cancer
title_full The role of mesenchymal stem cells derived exosomes as a novel nanobiotechnology target in the diagnosis and treatment of cancer
title_fullStr The role of mesenchymal stem cells derived exosomes as a novel nanobiotechnology target in the diagnosis and treatment of cancer
title_full_unstemmed The role of mesenchymal stem cells derived exosomes as a novel nanobiotechnology target in the diagnosis and treatment of cancer
title_short The role of mesenchymal stem cells derived exosomes as a novel nanobiotechnology target in the diagnosis and treatment of cancer
title_sort role of mesenchymal stem cells derived exosomes as a novel nanobiotechnology target in the diagnosis and treatment of cancer
topic mesenchymal stem cells
exosomes
biotechnology
cancer therapy
cancer diagnosis
url https://www.frontiersin.org/articles/10.3389/fbioe.2023.1214190/full
work_keys_str_mv AT youzhou theroleofmesenchymalstemcellsderivedexosomesasanovelnanobiotechnologytargetinthediagnosisandtreatmentofcancer
AT yuqingdong theroleofmesenchymalstemcellsderivedexosomesasanovelnanobiotechnologytargetinthediagnosisandtreatmentofcancer
AT aixuezhang theroleofmesenchymalstemcellsderivedexosomesasanovelnanobiotechnologytargetinthediagnosisandtreatmentofcancer
AT jibinwu theroleofmesenchymalstemcellsderivedexosomesasanovelnanobiotechnologytargetinthediagnosisandtreatmentofcancer
AT qiangsun theroleofmesenchymalstemcellsderivedexosomesasanovelnanobiotechnologytargetinthediagnosisandtreatmentofcancer
AT youzhou roleofmesenchymalstemcellsderivedexosomesasanovelnanobiotechnologytargetinthediagnosisandtreatmentofcancer
AT yuqingdong roleofmesenchymalstemcellsderivedexosomesasanovelnanobiotechnologytargetinthediagnosisandtreatmentofcancer
AT aixuezhang roleofmesenchymalstemcellsderivedexosomesasanovelnanobiotechnologytargetinthediagnosisandtreatmentofcancer
AT jibinwu roleofmesenchymalstemcellsderivedexosomesasanovelnanobiotechnologytargetinthediagnosisandtreatmentofcancer
AT qiangsun roleofmesenchymalstemcellsderivedexosomesasanovelnanobiotechnologytargetinthediagnosisandtreatmentofcancer